BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naseer M, Turse EP, Syed A, Dailey FE, Zatreh M, Tahan V. Interventions to improve sarcopenia in cirrhosis: A systematic review. World J Clin Cases 2019; 7(2): 156-170 [PMID: 30705893 DOI: 10.12998/wjcc.v7.i2.156] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S. Serum zinc concentration and quality of life in chronic liver diseases. Medicine (Baltimore) 2020;99:e18632. [PMID: 31895823 DOI: 10.1097/MD.0000000000018632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Siqueira MR, Pace FHL, Limongi TM, Henrique DMN, Mira PAC, Oliveira TMD, Oliveira CC, Aguiar AS, Malaguti C. Factors associated with the perceived benefits and barriers to physical activity in liver cirrhosis. Rev Assoc Med Bras (1992) 2021;67:271-6. [PMID: 34406252 DOI: 10.1590/1806-9282.67.02.20200692] [Reference Citation Analysis]
3 Saeki C, Tsubota A. Influencing Factors and Molecular Pathogenesis of Sarcopenia and Osteosarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:899. [PMID: 34575048 DOI: 10.3390/life11090899] [Reference Citation Analysis]
4 Nishikawa H, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Sarcopenia and Frailty in Liver Cirrhosis. Life (Basel) 2021;11:399. [PMID: 33925660 DOI: 10.3390/life11050399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Barbero-Becerra VJ, López-Méndez I, Romo-Araiza A, Visag-Castillo V, Chávez-Tapia NC, Uribe M, Juárez-Hernandez E. Sarcopenia in chronic liver diseases: a translational overview. Expert Rev Gastroenterol Hepatol 2020;14:355-66. [PMID: 32299261 DOI: 10.1080/17474124.2020.1757427] [Reference Citation Analysis]
6 Kochar B, Cai W, Cagan A, Ananthakrishnan AN. Frailty is independently associated with mortality in 11 001 patients with inflammatory bowel diseases. Aliment Pharmacol Ther 2020;52:311-8. [DOI: 10.1111/apt.15821] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 9.5] [Reference Citation Analysis]
7 Campion D, Giovo I, Ponzo P, Saracco GM, Balzola F, Alessandria C. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. World J Hepatol 2019; 11(6): 489-512 [PMID: 31293718 DOI: 10.4254/wjh.v11.i6.489] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
8 Lee MK, Chung WJ. Relationship between symptoms and both stage of change in adopting a healthy life style and quality of life in patients with liver cirrhosis: a cross-sectional study. Health Qual Life Outcomes 2021;19:148. [PMID: 34001156 DOI: 10.1186/s12955-021-01787-9] [Reference Citation Analysis]
9 Orsso CE, Montes-Ibarra M, Findlay M, van der Meij BS, de van der Schueren MAE, Landi F, Laviano A, Prado CM. Mapping ongoing nutrition intervention trials in muscle, sarcopenia, and cachexia: a scoping review of future research. J Cachexia Sarcopenia Muscle 2022;13:1442-59. [PMID: 35301816 DOI: 10.1002/jcsm.12954] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Teoh NC. Recent advances in the management of hepatocellular carcinoma: First, cut … is the deepest or is it "no-touch" and exercise? J Gastroenterol Hepatol 2019;34:481-2. [PMID: 30821411 DOI: 10.1111/jgh.14632] [Reference Citation Analysis]
11 Tsagkaris C, Papadakos SP, Moysidis DV, Papazoglou AS, Koutsogianni A, Papadakis M. Hepatomusculoskeletal disorders: Coining a new term might improve the management of the musculoskeletal manifestations of chronic liver disease. World J Gastrointest Pathophysiol 2022; 13(4): 124-127 [DOI: 10.4291/wjgp.v13.i4.124] [Reference Citation Analysis]
12 Santos LAA, Lima TB, Qi X, Paiva SAR, Romeiro FG. Refining dual-energy x-ray absorptiometry data to predict mortality among cirrhotic outpatients: A retrospective study. Nutrition 2021;85:111132. [PMID: 33545545 DOI: 10.1016/j.nut.2020.111132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Ismaiel A, Bucsa C, Farcas A, Leucuta D, Popa S, Dumitrascu DL. Effects of Branched-Chain Amino Acids on Parameters Evaluating Sarcopenia in Liver Cirrhosis: Systematic Review and Meta-Analysis. Front Nutr 2022;9:749969. [DOI: 10.3389/fnut.2022.749969] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mohta S, Anand A, Sharma S, Qamar S, Agarwal S, Gunjan D, Singh N, Madhusudhan KS, Pandey RM, Saraya A. Randomised clinical trial: effect of adding branched chain amino acids to exercise and standard-of-care on muscle mass in cirrhotic patients with sarcopenia. Hepatol Int 2022. [PMID: 35469091 DOI: 10.1007/s12072-022-10334-7] [Reference Citation Analysis]
15 Warner Ii ER, Satapathy SK. Sarcopenia in the Cirrhotic Patient: Current Knowledge and Future Directions. Journal of Clinical and Experimental Hepatology 2022. [DOI: 10.1016/j.jceh.2022.06.005] [Reference Citation Analysis]
16 Gonzalez A, Valero-Breton M, Huerta-Salgado C, Achiardi O, Simon F, Cabello-Verrugio C. Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Transl Myol 2021;31. [PMID: 33709647 DOI: 10.4081/ejtm.2021.9630] [Reference Citation Analysis]